Innovation to Impact: Dr. Lieping Chen and NextCure

Dr. Lieping Chen, the United Technologies Corporation Professor in Cancer Research and professor of immunobiology, dermatology, and medicine (medical oncology) and co-director of the Cancer Immunology Program at Yale Cancer Center, is a pioneer in the field of immuno-oncology. His discoveries have led to life-saving drugs for cancer patients. Now, with the support of the Yale Office of Cooperative Research, Chen has launched a startup — NextCure — that is poised to lead to even more breakthrough treatments.